businesspress24.com - Functional Technologies Reports Termination of Proposed Transaction
 

Functional Technologies Reports Termination of Proposed Transaction

ID: 1166530

(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 11/01/12 -- Functional Technologies Corp. (TSX VENTURE: FEB)(OTCQX: FEBTF) reports the termination of the spin-out agreement announced on July 19, 2012 regarding the proposed sale of Phyterra Bio Inc. and Maritime Pulse Drying Inc., as well as certain assets of Phyterra Yeast Inc., due to certain conditions precedent, including government agency approval, not being satisfied or waived. The company is reviewing alternative strategies regarding the non-core assets that were the subject of the spin-out agreement in furtherance of streamlining its operations and strategic focus.

Christopher Morris, Chief Executive Officer

About Functional Technologies Corp.

Functional Technologies develops and commercializes proprietary, advanced yeast-based solutions to significant challenges in the food, beverage and healthcare industries. The Company's platform improves the performance of innate yeast functions, and prevents the formation of naturally occurring toxins and contaminants that either affect final product quality or are classified by the World Health Organization ("WHO") as probable human carcinogens. Functional Technologies' lead technologies include yeasts that prevent and reduce the formation of foul-smelling hydrogen sulphide (H2S) and the WHO classified probable carcinogen, acrylamide - both by-products of food and beverage processing. These contaminants are found in many commonly consumed items, such as fermented food products and alcoholic beverages, and baked and fried foods. For more information, please visit our website at .

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.



Contacts:
Functional Technologies Corp.
Geoff Lee
VP, Business Development
+1.604.648.2200
+1.604.648.2201 (FAX)






Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  ProMetic Presenting Positive New Anti-Fibrotic Data at the American Society of Nephrology Annual Meeting in San Diego
Threshold Pharmaceuticals Reports Third Quarter 2012 Financial and Operational Results
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 01.11.2012 - 19:05 Uhr
Sprache: Deutsch
News-ID 1166530
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

VANCOUVER, BRITISH COLUMBIA


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 215 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Functional Technologies Reports Termination of Proposed Transaction
"
steht unter der journalistisch-redaktionellen Verantwortung von

Functional Technologies Corp. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Functional Technologies Corp.



 

Who is online

All members: 10 566
Register today: 1
Register yesterday: 0
Members online: 0
Guests online: 105


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.